The estimated Net Worth of William S Reardon is at least $31.7 mil dollars as of 25 February 2021. Mr. Reardon owns over 1,460 units of abrdn Healthcare Opportunities Fund stock worth over $31,726 and over the last 17 years he sold THQ stock worth over $0. In addition, he makes $0 as Independent Trustees at abrdn Healthcare Opportunities Fund.
Sign up
Mr. Reardon THQ stock SEC Form 4 insiders trading
William has made over 9 trades of the abrdn Healthcare Opportunities Fund stock since 2008, according to the Form 4 filled with the SEC. Most recently he bought 1,460 units of THQ stock worth $25,024 on 25 February 2021.
The largest trade he's ever made was buying 13,561 units of abrdn Healthcare Opportunities Fund stock on 16 September 2013 worth over $24,681. On average, William trades about 607 units every 150 days since 2008. As of 25 February 2021 he still owns at least 1,460 units of abrdn Healthcare Opportunities Fund stock.
You can see the complete history of Mr. Reardon stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
William Reardon biography
William S. Reardon CPA serves as Independent Trustees of the Company. His personal experience as a Life Science audit partner at PricewaterhouseCoopers LLP ("PwC"), with a broad spectrum of companies across the corporate life cycle from startup to successful product driven pharmaceutical companies, provides each Fund with a valuable perspective in analyzing life science company opportunities and in valuing the venture portion of the portfolio. Until 2002, Mr. Reardon was a business assurance partner in PwC's Boston office and leader of the Life Sciences Industry Practice for New England and the Eastern U.S., working closely with many of the Firm's public clients in SEC-registered equity, convertible and R&D limited partnership offerings and many initial public offerings. He serves on the Valuation Committee and as Chair of the Audit Committee of each Fund. From 1998-2000 he served on the Board of the Emerging Companies Section of the Biotechnology Industry Organization ("BIO") and from 2000 to 2002 he served on the Board of Directors of the Massachusetts Biotechnology Council ("MBC"). During his professional career, he was a frequent speaker at BIO conferences and MBC Industry meetings on issues affecting biotechnology companies. He also served as a board member and audit committee chair of a development-stage public company, Idera Pharmaceuticals from 2002 until March, 2019. Until 2018, Mr. Reardon was a member of the American Institute of CPAs and the Massachusetts Society of CPAs. He holds an MBA from Harvard Business School and a BA in East Asian History from Harvard College.
How old is William Reardon?
William Reardon is 74, he's been the Independent Trustees of abrdn Healthcare Opportunities Fund since 2014. There are no older and 6 younger executives at abrdn Healthcare Opportunities Fund.
What's William Reardon's mailing address?
William's mailing address filed with the SEC is 167 Sidney St, Cambridge, MA 02139, USA.
Insiders trading at abrdn Healthcare Opportunities Fund
Over the last 10 years, insiders at abrdn Healthcare Opportunities Fund have traded over $0 worth of abrdn Healthcare Opportunities Fund stock and bought 44,516 units worth $798,865 . The most active insiders traders include Daniel R Omstead, Jeffrey Allen Bailey y Michael W Bonney. On average, abrdn Healthcare Opportunities Fund executives and independent directors trade stock every 214 days with the average trade being worth of $56,911. The most recent stock trade was executed by Rose Di Martino on 16 July 2024, trading 1,000 units of THQ stock currently worth $21,300.
What does abrdn Healthcare Opportunities Fund do?
tekla life sciences investors is a closed-ended equity mutual fund launched and managed by tekla capital management llc. the fund invests in public equity markets across the globe. it seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. the fund primarily invests in growth stocks of small cap companies. it employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. the fund benchmarks the performance of its portfolio against the nasdaq biotech index and the s&p 500 index. it was form
What does abrdn Healthcare Opportunities Fund's logo look like?
Complete history of Mr. Reardon stock trades at Idera Pharmaceuticals, abrdn Healthcare Investors, abrdn Life Sciences Investors, abrdn Healthcare Opportunities Fund y abrdn World Healthcare Fund
abrdn Healthcare Opportunities Fund executives and stock owners
abrdn Healthcare Opportunities Fund executives and other stock owners filed with the SEC include:
-
Thomas Kent,
Independent Trustee -
Lucinda Stebbins,
Independent Trustees -
William Reardon,
Independent Trustees -
Oleg Pohotsky,
Independent Chairman of the Board of Trustee -
Rakesh Jain,
Independent Trustees -
Laura Woodward,
Chief Compliance Officer, Treasurer, Secretary -
Daniel Omstead,
President, Trustee -
Dr. Daniel R. Omstead M.S, Ph.D.,
Pres and Trustee -
Michael W Bonney,
Director -
Kathleen Goetz,
Director -
Bill Maher,
Director -
Jeffrey Allen Bailey,
Director -
Rose Di Martino,
Director -
Todd Reit,
Director